Eugia US LLC

67 drugs in NADAC|67 Generic,0 Brand

Eugia US LLC lists 67 NDCs in the CMS NADAC file (67 generic, 0 brand), at an average NADAC of $12.85 per unit, with a week-over-week move of -1.4% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.

Total Drugs

67G / 0B

Avg Price / Unit

$12.8466

$0.07 – $197.61

Avg 7d Change

-1.39%

Across 34 drugs with changes

7d Activity

13↑21↓33 flat

of 67 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Keep following this manufacturer

These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.

Lead market

Lidocaine Hydrochloride market

See the molecule this manufacturer shows up in most often and compare it against competing suppliers.

Lead class

Amide Local Anesthetic therapeutic class

Review the broader class where Eugia US LLC has the strongest current portfolio footprint.

Trend hub

Portfolio trend view

Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.

Guide

NADAC pricing primer

Use the explainer for context on the benchmark this manufacturer is being compared against.

Frequently Asked Questions

How many drugs does Eugia US LLC make?

Eugia US LLC lists 67 NDCs in the CMS NADAC file — 67 generic and 0 brand products.

What is the average price of Eugia US LLC drugs?

The average NADAC across Eugia US LLC's portfolio is $12.8466 per unit, ranging from $0.0681 to $197.6060.

What types of drugs does Eugia US LLC make?

Eugia US LLC makes drugs across 29 FDA pharmacologic classes. The most common by NDC count are Amide Local Anesthetic (14), Antiarrhythmic (14), Corticosteroid (9), Penicillin-class Antibacterial (5), Factor Xa Inhibitor (4).

Has Eugia US LLC had any drug recalls?

17 FDA recalls are matched to Eugia US LLC in the openFDA feed, most recently on May 18, 2026.

How has Eugia US LLC's pricing changed recently?

Over the past 7 days, 13 Eugia US LLC products rose and 21 fell, with a portfolio-wide average change of -1.4%.

Drug Portfolio

67 drugs total, 67 shown

Drug ↕	NDC	Price	7d Change ↕	Class	Market Outlier	Therapeutic Class
LEUPROLIDE 2WK 14 MG/2.8 ML KT LEUPROLIDE ACETATE	55150047801	$197.6060 per EA	—	Generic	—	—
FONDAPARINUX 5 MG/0.4 ML SYR FONDAPARINUX SODIUM	55150023110	$55.3125 per ML	—	Generic	—	Factor Xa Inhibitor
IBANDRONATE 3 MG/3 ML SYRINGE Ibandronate Sodium	55150019183	$52.6478 per ML	—	Generic	—	Bisphosphonate
FONDAPARINUX 10 MG/0.8 ML SYR FONDAPARINUX SODIUM	55150023310	$44.8161 per ML	-2.64%	Generic	—	Factor Xa Inhibitor
BORTEZOMIB 3.5 MG VIAL BORTEZOMIB	55150033701	$43.3460 per EA	—	Generic	—	Proteasome Inhibitor
FONDAPARINUX 7.5 MG/0.6 ML SYR FONDAPARINUX SODIUM	55150023210	$42.8089 per ML	+0.23%	Generic	—	Factor Xa Inhibitor
FOSAPREPITANT 150 MG VIAL FOSAPREPITANT DIMEGLUMINE	55150029901	$38.5080 per EA	—	Generic	—	Substance P/Neurokinin-1 Receptor Antagonist
MEDROXYPROGESTERONE 150 MG/ML MEDROXYPROGESTERONE ACETATE	55150033001	$27.3638 per ML	-3.96%	Generic	—	Progestin
ERTAPENEM 1 GRAM VIAL Ertapenem	55150028220	$26.6295 per EA	-4.06%	Generic	—	Penem Antibacterial
ERTAPENEM 1 GRAM VIAL Ertapenem	55150028209	$26.6295 per EA	-4.06%	Generic	—	Penem Antibacterial
AMPICILLIN-SULBACTAM 15 GM VL Ampicillin Sodium and Sulbactam Sodium	55150011899	$24.6333 per EA	—	Generic	—	Penicillin-class Antibacterial, beta Lactamase Inhibitor
DAPTOMYCIN 500 MG VIAL DAPTOMYCIN	55150034401	$23.7984 per EA	+4.90%	Generic	—	Lipopeptide Antibacterial
MEDROXYPROGESTERONE 150 MG/ML MEDROXYPROGESTERONE ACETATE	55150032925	$22.8495 per ML	—	Generic	—	Progestin
FONDAPARINUX 2.5 MG/0.5 ML SYR FONDAPARINUX SODIUM	55150023010	$22.1623 per ML	—	Generic	—	Factor Xa Inhibitor
OLANZAPINE 10 MG VIAL OLANZAPINE	55150030801	$20.9230 per EA	-2.08%	Generic	—	Atypical Antipsychotic
MEDROXYPROGESTERONE 150 MG/ML MEDROXYPROGESTERONE ACETATE	55150032901	$18.8535 per ML	+2.95%	Generic	—	Progestin
SUMATRIPTAN 6 MG/0.5 ML VIAL Sumatriptan	55150017301	$14.9345 per ML	-2.05%	Generic	—	Serotonin-1b and Serotonin-1d Receptor Agonist
SUMATRIPTAN 6 MG/0.5 ML VIAL Sumatriptan	55150017305	$14.9345 per ML	-2.05%	Generic	—	Serotonin-1b and Serotonin-1d Receptor Agonist
METHYLPREDNISOLONE 400 MG/5 ML Methylprednisolone Acetate	55150031401	$13.4236 per ML	—	Generic	—	Corticosteroid
NALOXONE 2 MG/2 ML SYRINGE Naloxone Hydrochloride	55150034510	$12.7410 per ML	-5.65%	Generic	—	Opioid Antagonist
TESTOSTERONE CYP 200 MG/ML Testosterone Cypionate	55150027701	$11.3924 per ML	-1.33%	Generic	—	Androgen
NALOXONE 4 MG/10 ML VIAL NALOXONE HYDROCHLORIDE	55150032810	$11.2094 per ML	—	Generic	—	Opioid Antagonist
FLUPHENAZINE DEC 125 MG/5 ML FLUPHENAZINE DECANOATE	55150026705	$10.8440 per ML	-0.44%	Generic	—	Phenothiazine
NALOXONE 0.4 MG/ML VIAL Naloxone Hydrochloride	55150032710	$8.0996 per ML	—	Generic	—	Opioid Antagonist
METHYLPREDNISOLONE 400 MG/10 ML Methylprednisolone Acetate	55150031301	$5.8078 per ML	—	Generic	—	Corticosteroid
EPHEDRINE SULFATE 50 MG/ML VL Ephedrine Sulfate	55150037325	$5.6366 per ML	—	Generic	—	Norepinephrine Releasing Agent, alpha-Adrenergic Agonist, beta-Adrenergic Agonist
TRIAMCINOLONE ACET 200 MG/5 ML Triamcinolone Acetonide	55150038401	$5.5980 per ML	—	Generic	—	Corticosteroid
TRIAMCINOLONE ACET 400 MG/10 ML Triamcinolone Acetonide	55150038501	$5.1457 per ML	—	Generic	—	Corticosteroid
MEROPENEM IV 1 GM VIAL Meropenem	55150020830	$4.6875 per EA	+0.40%	Generic	—	Penem Antibacterial
TESTOSTERONE CYP 1,000 MG/10 ML Testosterone Cypionate	55150027601	$4.5281 per ML	-9.36%	Generic	—	Androgen
AMPICILLIN-SULBACTAM 3 GM VIAL Ampicillin Sodium and Sulbactam Sodium	55150011720	$4.3164 per EA	—	Generic	—	Penicillin-class Antibacterial, beta Lactamase Inhibitor
AMPICILLIN 1 GM VIAL Ampicillin Sodium	55150011310	$4.3059 per EA	—	Generic	—	Penicillin-class Antibacterial
TESTOSTERONE CYP 2,000 MG/10 ML Testosterone Cypionate	55150027801	$3.5819 per ML	-1.89%	Generic	—	Androgen
AZITHROMYCIN I.V. 500 MG VIAL Azithromycin	55150017410	$3.5270 per EA	—	Generic	High Outlier	Macrolide Antimicrobial
PIPERACIL-TAZOBACT 3.375 GM VL Piperacillin Sodium and Tazobactam Sodium	55150012030	$3.4926 per EA	—	Generic	—	Penicillin-class Antibacterial, beta Lactamase Inhibitor
AMPICILLIN 2 GM VIAL Ampicillin Sodium	55150011420	$3.2338 per EA	—	Generic	—	Penicillin-class Antibacterial
MEROPENEM IV 500 MG VIAL Meropenem	55150020720	$2.8678 per EA	—	Generic	—	Penem Antibacterial
PANTOPRAZOLE SODIUM 40 MG VIAL Pantoprazole Sodium	55150020210	$2.3740 per EA	—	Generic	—	Proton Pump Inhibitor
THIAMINE 200 MG/2 ML VIAL Thiamine Hydrochloride	55150027325	$2.2468 per ML	+3.90%	Generic	—	—
DEXAMETHASONE 4 MG/ML VIAL DEXAMETHASONE SODIUM PHOSPHATE	55150023701	$1.3879 per ML	—	Generic	—	Corticosteroid
PROGESTERONE 500 MG/10 ML VIAL Progesterone	55150030610	$1.3605 per ML	-5.22%	Generic	—	Progesterone
GENTAMICIN 80 MG/2 ML VIAL Gentamicin	55150040225	$1.3026 per ML	-4.04%	Generic	—	Aminoglycoside Antibacterial
DEXAMETHASONE 10 MG/ML VIAL Dexamethasone Sodium Phosphate	55150030425	$1.1568 per ML	-10.52%	Generic	—	Corticosteroid
DEXAMETHASONE 100 MG/10 ML VL Dexamethasone Sodium Phosphate	55150030510	$0.9309 per ML	—	Generic	—	Corticosteroid
LIDOCAINE HCL 1% 20 MG/2 ML VL Lidocaine Hydrochloride	55150016102	$0.8379 per ML	-3.77%	Generic	—	Amide Local Anesthetic, Antiarrhythmic
LIDOCAINE HCL 1% 20 MG/2 ML VL Lidocaine Hydrochloride	55150016109	$0.8379 per ML	-3.77%	Generic	—	Amide Local Anesthetic, Antiarrhythmic
KETAMINE 500 MG/10 ML VIAL KETAMINE HYDROCHLORIDE	55150043910	$0.5563 per ML	-0.30%	Generic	Low Outlier	General Anesthetic
FUROSEMIDE 20 MG/2 ML VIAL Furosemide	55150032225	$0.4901 per ML	+6.18%	Generic	—	Loop Diuretic
TRANEXAMIC ACID 1,000 MG/10 ML Tranexamic Acid	55150018810	$0.4035 per ML	+4.32%	Generic	—	Antifibrinolytic Agent
ROCURONIUM 50 MG/5 ML VIAL Rocuronium Bromide	55150022505	$0.3942 per ML	—	Generic	—	Nondepolarizing Neuromuscular Blocker
LIDOCAINE HCL 2% 100 MG/5 ML Lidocaine Hydrochloride	55150016509	$0.3487 per ML	—	Generic	—	Amide Local Anesthetic, Antiarrhythmic
LIDOCAINE HCL 2% 100 MG/5 ML Lidocaine Hydrochloride	55150016505	$0.3487 per ML	—	Generic	—	Amide Local Anesthetic, Antiarrhythmic
LIDOCAINE HCL 1% 50 MG/5 ML VIAL Lidocaine Hydrochloride	55150016205	$0.3331 per ML	+3.39%	Generic	—	Amide Local Anesthetic, Antiarrhythmic
LIDOCAINE HCL 1% 50 MG/5 ML VL Lidocaine Hydrochloride	55150016209	$0.3331 per ML	+3.39%	Generic	—	Amide Local Anesthetic, Antiarrhythmic
ONDANSETRON 40 MG/20 ML VIAL Ondansetron Hydrochloride	55150012620	$0.3226 per ML	—	Generic	—	Serotonin-3 Receptor Antagonist
FUROSEMIDE 40 MG/4 ML VIAL Furosemide	55150032325	$0.2525 per ML	-4.99%	Generic	—	Loop Diuretic
DEXAMETHASONE 120 MG/30 ML VL DEXAMETHASONE SODIUM PHOSPHATE	55150023930	$0.2276 per ML	—	Generic	—	Corticosteroid
ONDANSETRON HCL 4 MG/2 ML VIAL Ondansetron Hydrochloride	55150012502	$0.1968 per ML	—	Generic	—	Serotonin-3 Receptor Antagonist
DEXAMETHASONE 20 MG/5 ML VIAL DEXAMETHASONE SODIUM PHOSPHATE	55150023805	$0.1807 per ML	—	Generic	—	Corticosteroid
LIDOCAINE HCL 1% VIAL Lidocaine Hydrochloride	55150025110	$0.1378 per ML	—	Generic	—	Amide Local Anesthetic, Antiarrhythmic
LIDOCAINE HCL 1% 100 MG/10 ML Lidocaine Hydrochloride	55150025124	$0.1378 per ML	—	Generic	—	Amide Local Anesthetic, Antiarrhythmic
LIDOCAINE HCL 2% VIAL Lidocaine Hydrochloride	55150025520	$0.0762 per ML	-4.25%	Generic	—	Amide Local Anesthetic, Antiarrhythmic
LIDOCAINE HCL 2% 400 MG/20 ML Lidocaine Hydrochloride	55150025524	$0.0762 per ML	-4.25%	Generic	—	Amide Local Anesthetic, Antiarrhythmic
LIDOCAINE HCL 1% 200 MG/20 ML Lidocaine Hydrochloride	55150025224	$0.0700 per ML	+0.87%	Generic	—	Amide Local Anesthetic, Antiarrhythmic
LIDOCAINE HCL 1% VIAL Lidocaine Hydrochloride	55150025220	$0.0700 per ML	+0.87%	Generic	—	Amide Local Anesthetic, Antiarrhythmic
LIDOCAINE HCL 1% 300 MG/30 ML Lidocaine Hydrochloride	55150016300	$0.0681 per ML	+1.02%	Generic	—	Amide Local Anesthetic, Antiarrhythmic
LIDOCAINE HCL 1% 300 MG/30 ML Lidocaine Hydrochloride	55150016330	$0.0681 per ML	+1.02%	Generic	—	Amide Local Anesthetic, Antiarrhythmic

FDA Recalls (17)

Recalls matched by company name. Verify current status with FDA.

D-0552-2026 →

Ongoing

Class III

Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02

Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Initiated: 5/18/2026

D-0472-2025 →

Ongoing

Class II

Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25

Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.

Initiated: 5/29/2025

D-0390-2025 →

Ongoing

Class II

Tirofiban Hydrochloride Injection 12.5 mg/250 mL (50 mcg/mL), 250 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-430-01

Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.

Initiated: 4/21/2025

D-0389-2025 →

Ongoing

Class II

Tirofiban Hydrochloride Injection 5 mg/100 mL (50 mcg/mL), 100 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-429-01

Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.

Initiated: 4/21/2025

D-0363-2025 →

Ongoing

Class II

Testosterone Cypionate Injection, USP, CIII, 200mg per mL, Rx only, 1mL Single-Dose Vial, Distributed by Eugia US LLC, E. Windsor, NJ, Manufactured by: Eugia Specialties Limited, Telangana State, India, NDC 55150-277-01

cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.

Initiated: 4/10/2025

D-0186-2025 →

Ongoing

Class II

Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor NJ 08520 NDC # 55150-306-10

Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.

Initiated: 12/27/2024

D-0185-2025 →

Ongoing

Class II

medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, Rx only, 1 mL Single-Dose Vial, Mfd in India for: Eugia US LLC, NJ 08520 NDC 55150-329-01 Shipper label: medroxyPROGESTERone Acetate Injectable Suspension, USP, 150 mg per mL, Distributed by: Eugia US LLC, NJ, Manufactured by: Eugia Pharma Specialties Limited, India

CGMP Deviations

Initiated: 12/18/2024

D-0624-2024 →

Ongoing

Class II

Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E Windsor, NJ 08520, NDC 55150-306-10.

Presence of Particulate Matter: Complaint received of a glass particle in the vial.

Initiated: 7/26/2024

D-0555-2024 →

Ongoing

Class II

Dexamethasone Sodium Phosphate injection USP, 120mg per 30mL (4mg/mL), 30 mL Multiple-Dose Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520, Made in India, NDC 55150-239-30

Failed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.

Initiated: 5/23/2024

D-0556-2024 →

Ongoing

Class III

Eptifibatide injection 20mg/10mL (2mg/mL), 10mL Single-Dose Vial, Rx only, Mfd. In India for: AuroMedics Pharma, LLC, E. Windsor, NJ 08520, NDC 55150-219-10

Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.

Initiated: 5/22/2024

D-0385-2024 →

Terminated

Class II

Tobramycin for Injection, USP, 1.2 grams per Pharmacy Bulk Package, Rx Only, For Intravenous Use, PHARMACY BULK PACKAGE NOT FOR DIRECT INFUSION, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, Carton NDC 55150-470-06, Vial NDC 55150-470-01.

Failed Stability Specification: Water determination was found not complying with specification.

Initiated: 2/22/2024

D-0366-2024 →

Ongoing

Class II

Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01

Failed Dissolution Specifications

Initiated: 2/20/2024

D-0391-2024 →

Ongoing

Class II

Nicardipine Hydrochloride Injection, USP 25mg/mL (2.5 mg/mL) 10 mL vials, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520, NDC 55150-183-11

Failed Impurities/Degradation Specifications: Out of specification for organic impurities

Initiated: 2/20/2024

D-0390-2024 →

Ongoing

Class II

Nicardipine Hydrochloride Injection (2.5mg/mL), US, 25mg per 10mL, 10mL Vial, Rx only, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520 NDC 55150-183-10

Failed Impurities/Degradation Specifications: Out of specification for organic impurities

Initiated: 2/20/2024

D-0440-2024 →

Ongoing

Class I

Methocarbamol Injection, USP 1000mg/10mL, (100mg/mL), 10 mL Single-Dose Vial packed 25 vials per carton, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor, NJ 08520, NDC 55150-223-10

Presence of Particulate Matter

Initiated: 2/15/2024

D-0041-2024 →

Ongoing

Class II

Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per 10 mL (40mg/mL), 10 mL Multiple Dose Vial, Rx Only, For Intramuscular or Intra-articular use only, Shake Well, Not for IV/ID, intraocular, epidural, or intrathecal use, Mfd. in India for Auromedics Pharma LLC., E Windsor, NJ, 08520, NDC 55150-385-01.

Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial.

Initiated: 9/28/2023

D-0095-2023 →

Ongoing

Class II

Acyclovir Sodium Injection 1,000 mg per 20 mL* (50 mg/mL); Single Dose 20mL Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd, E. Windsor, NJ 08520; Made in India. NDC 55150-155-20

Presence of Particulate Matter: Customer complaint of dark particles found inside the vial

Initiated: 12/28/2022